| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $760K | +1673.0% | +21.1% |
| SG&A Expense | $387K | -92.3% | -92.8% |
| Net Income | -$1.1M | +78.3% | +81.6% |
| EPS (Basic) | -$0.03 | -117.6% | +85.0% |
| EPS (Diluted) | -$0.03 | -117.6% | +85.0% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $7.4M | +792.2% | +610.4% |
| Total Assets | $7.4M | +792.2% | +610.4% |
| Current Liabilities | $423K | +21.4% | -29.5% |
| Total Liabilities | $423K | +21.4% | -29.5% |
| Stockholders' Equity | $7.0M | +1350.3% | +1478.8% |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.5M | — | — |
| Financing Cash Flow | $8.6M | — | — |